FI921475L - 1,4-dihydro-4-oxo-3-kinolinderivat som selektivt toxiska antibakteriella aemenn hos daeggdjur. - Google Patents

1,4-dihydro-4-oxo-3-kinolinderivat som selektivt toxiska antibakteriella aemenn hos daeggdjur. Download PDF

Info

Publication number
FI921475L
FI921475L FI921475A FI921475A FI921475L FI 921475 L FI921475 L FI 921475L FI 921475 A FI921475 A FI 921475A FI 921475 A FI921475 A FI 921475A FI 921475 L FI921475 L FI 921475L
Authority
FI
Finland
Prior art keywords
daeggdjur
aemenn
hos
dihydro
oxo
Prior art date
Application number
FI921475A
Other languages
English (en)
Finnish (fi)
Other versions
FI921475A7 (fi
FI921475A0 (fi
Inventor
Paul R Mcguirk
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI921475A7 publication Critical patent/FI921475A7/fi
Publication of FI921475A0 publication Critical patent/FI921475A0/fi
Publication of FI921475L publication Critical patent/FI921475L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI921475A 1989-10-06 1989-10-06 1,4-dihydro-4-oxo-3-kinolinderivat som selektivt toxiska antibakteriella aemenn hos daeggdjur. FI921475L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/004438 WO1991004972A1 (en) 1989-10-06 1989-10-06 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents

Publications (3)

Publication Number Publication Date
FI921475A7 FI921475A7 (fi) 1992-04-03
FI921475A0 FI921475A0 (fi) 1992-04-03
FI921475L true FI921475L (fi) 1992-04-03

Family

ID=22215279

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921475A FI921475L (fi) 1989-10-06 1989-10-06 1,4-dihydro-4-oxo-3-kinolinderivat som selektivt toxiska antibakteriella aemenn hos daeggdjur.

Country Status (12)

Country Link
EP (1) EP0421668B1 (pt)
JP (1) JPH03130286A (pt)
AT (1) ATE116649T1 (pt)
CA (1) CA2026972A1 (pt)
DE (1) DE69015756T2 (pt)
DK (1) DK0421668T3 (pt)
ES (1) ES2066147T3 (pt)
FI (1) FI921475L (pt)
GR (1) GR3015002T3 (pt)
IE (1) IE64194B1 (pt)
PT (1) PT95519B (pt)
WO (1) WO1991004972A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
US7902227B2 (en) * 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
IN166416B (pt) * 1985-09-18 1990-05-05 Pfizer
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
JPS63198664A (ja) * 1986-03-31 1988-08-17 Sankyo Co Ltd キノロンカルボン酸誘導体
EP0241206A3 (en) * 1986-03-31 1989-05-10 Sankyo Company Limited Quinoline-3-carboxylic acid derivatives, their preparation and use
DE3641312A1 (de) * 1986-12-03 1988-06-09 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent

Also Published As

Publication number Publication date
JPH03130286A (ja) 1991-06-04
IE903566A1 (en) 1991-04-10
ATE116649T1 (de) 1995-01-15
FI921475A7 (fi) 1992-04-03
IE64194B1 (en) 1995-07-12
PT95519A (pt) 1991-08-14
EP0421668A2 (en) 1991-04-10
DE69015756T2 (de) 1995-05-11
FI921475A0 (fi) 1992-04-03
EP0421668A3 (en) 1991-08-07
EP0421668B1 (en) 1995-01-04
PT95519B (pt) 1997-07-31
DK0421668T3 (da) 1995-03-20
WO1991004972A1 (en) 1991-04-18
CA2026972A1 (en) 1991-04-07
DE69015756D1 (de) 1995-02-16
ES2066147T3 (es) 1995-03-01
GR3015002T3 (en) 1995-05-31

Similar Documents

Publication Publication Date Title
FI913215A0 (fi) Additionspolymeriseringskatalysator, som aktiveras medelst oxidering.
FI914861A7 (fi) Med klistermekanism fungerande maetsensor foer oxygenhalt hos blodpuls, med en aoteranvaendbar del.
FI931367L (fi) Tvaettmedelskompositioner, som innehaoller polyhydroxifettsyraamider ochen skumfoerstaerkare
FI914329A0 (fi) Bubblande, brandhaemmande belaeggnings- material.
FI903028A0 (fi) Polymerbaserade blandningskompositioner, som innehaoller destrukturerad staerkelse.
FI900870A0 (fi) Foerfarande foer belaeggning av papper med kompositioner, som innehaoller mikrokapslar.
FI906436L (fi) Organiska, svavel innehaollande polyfluorfoereningar.
DE69427286D1 (de) 7,42-bis (o-demethyl)rapamycin
FI932596A7 (fi) 7-substituerad-6-fluor-1,4-dihydro-oxokinolin-3-karboxylsyrafoereningar anvaendbara som antibakteriska aemnen
FI923290A0 (fi) Imidazo (2,1-b)bensotiazol-3 -acetamidderivat.
FI905020A0 (fi) Orala kompositioner, som innehaoller monoperoxisyror.
FI920080A0 (fi) Kulfaongare, som uppstannar kulor.
FI932873A7 (fi) D-homo-(16-en)-11b-aryl-4-estrener, foerfarande foer deras framstaellningoch deras anvaendning som laekemedel
FI932654L (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
DE3780156D1 (de) Herbizide 1,5-diphenyl-1h-1,2,4-triazol-3-carboxamidderivate.
FI916018L (fi) 1,3-dioxolanderivat som kolesterol- saenkande medel.
FI921475L (fi) 1,4-dihydro-4-oxo-3-kinolinderivat som selektivt toxiska antibakteriella aemenn hos daeggdjur.
FI915623L (fi) 2b,19-etylenbryggsteroider som aromatasinhibitorer.
FI932446L (fi) 2b,19-metylaminobrosteroider som aromatasinhibitorer
DE58903154D1 (de) 2,2-difluorcyclopropyl-derivate.
FI903237A0 (fi) Fenoxipyridinaminer och deras derivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI903774A0 (fi) Ogarvade, biologiskt stabila skinn i fuktig form.
FI906269A0 (fi) 2,19-metylenoxi- och 2,19-metylentio -tvaerbundna steroider som aromatas- och 19-hydroxylasinhibitorer.
FI902902A0 (fi) Foerfarande foer framstaellning av flexibelt polyuretanskum medelst anvaendning av 1,1,1-trikloretan som skumaemne.
MX9202291A (es) Derivados carboxamido-(3,2n)-carbociclico-2-amino tetralinas.